BostonGene

BostonGene helps drug developers de-risk and accelerate research using a clinically validated AI platform for oncology, supported by a CLIA-certified, CAP-accredited laboratory. By integrating molecular and immune profiling with clinical data, we uncover insights that inform trial design, optimize patient selection, and improve outcomes. Our solutions are used in clinical settings to personalize care and guide therapy decisions for patients.